current and emerging role of radiogenomics in risk assessment for prostate cancer
Published 3 years ago • 455 plays • Length 15:45Download video MP4
Download video MP3
Similar videos
-
11:43
current and emerging role of radiogenomics in risk assessment for focal therapy
-
16:41
current and emerging role of radiogenomics
-
10:50
urologic perspective on the current and emerging role of multi-modality imaging and radiogenomics
-
6:18
updates of changes in the early detection of prostate cancer nccn guidelines 2021
-
11:20
evaluation and management of localized and recurrent prostate cancer: genetic cancer profiling
-
12:50
imaging tools for improving risk assessment and patient selection for biopsy
-
8:53
pro: the role of currently available biomarkers genomics in risk stratification of prostate cancer
-
56:52
pelvic mass management
-
12:35
radiologic perspective on the clinical utility of and emerging data on micro-ultrasound
-
15:43
role of mri in the current management of prostate cancer
-
20:48
mri in the enhanced detection of prostate cancer: what urologists need to know
-
22:27
highlights from the 5th global summit on precision diagnosis and treatment of prostate cancer
-
16:22
role of parp inhibitors in prostate cancer
-
14:18
prostate inflammation and prostate cancer: what do i need to know?
-
10:06
imaging tools for improving risk assessment, selection of patients for biopsy, and tissue sampling
-
10:56
con: the role of currently available biomarkers genomics in risk stratification of prostate cancer
-
10:42
advanced prostate cancer: what's changing
-
30:34
expanding the role of surgical management of high risk prostate cancer
-
20:23
active surveillance criteria and follow-up protocol